Fri, May 9, 10:01 AM (9 days ago)
### McKesson Corporation (MCK) Financial Performance Summary **Revenue:** $359.1 billion (up 16% YoY) - **Growth Drivers:** Market growth in the U.S. Pharmaceutical segment, higher volumes from retail national account customers, and growth in specialty pharmaceuticals. **Gross Profit:** $13.3 billion (up 4% YoY) - **Gross Profit Margin:** 3.71% (down 44 basis points YoY) - **Growth Drivers:** Growth in specialty pharmaceuticals, retail national account customers, and share of antitrust legal settlements. **Operating Expenses:** $8.9 billion (flat YoY) - **Operating Margin:** 12.2% (up 41 basis points YoY) - **Expenses:** Selling, distribution, general, and administrative expenses ($8.5 billion), claims and litigation charges ($108 million), and restructuring, impairment, and related charges ($286 million). **Net Income:** $3.3 billion (up 10% YoY) - **Earnings Per Share (EPS):** $25.72 (up 15% YoY) **Cash Flow from Operations:** $6.1 billion (up 43% YoY) - **Capital Expenditures:** $537 million (up 25% YoY) **Debt:** $5.7 billion (up 2% YoY) - **Cash and Cash Equivalents:** $5.7 billion (up 26% YoY) **Share Repurchases:** $3.1 billion (up 3% YoY) - **Dividends:** $345 million (up 10% YoY) **Segment Performance:** - **U.S. Pharmaceutical:** $327.7 billion (up 18% YoY) - **Prescription Technology Solutions:** $5.2 billion (up 9% YoY) - **Medical-Surgical Solutions:** $11.4 billion (up 1% YoY) - **International:** $14.7 billion (up 4% YoY) **Future Outlook:** - **Growth Drivers:** Continued market growth, strategic acquisitions, and operational efficiencies. - **Risk Factors:** Regulatory challenges, competitive pressures, and economic uncertainties. **Financial Condition:** - **Liquidity:** Strong, with $5.7 billion in cash and cash equivalents and a $4.0 billion revolving credit facility. - **Capital Resources:** Adequate, with access to capital and credit markets. **Market Position:** - **Competitive Landscape:** Strong, with a diversified product and service offerings. - **Market Share:** Leading position in the U.S. pharmaceutical distribution market. **Strategic Overview:** - **Growth Strategy:** Focus on expanding biopharma services, oncology, and specialty care platforms. - **Operational Efficiencies:** Initiatives to drive cost optimization and streamline operations. **Risk Factors:** - **Regulatory:** Compliance with complex healthcare, environmental, and data protection laws. - **Operational:** Dependence on key suppliers and customers, and exposure to economic downturns. - **Financial:** Exposure to interest rate and foreign currency exchange rate fluctuations.